Alert: Rating Upgrade (11/17/23)-Amphastar Pharmaceuticals Inc (NASDAQ: AMPH).


Stock Rating Upgrade

In the last week the Value Trend Rating for Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) improved from C to B reflecting improving fundamentals and high Appreciation Potential.


Recent Price Action

On 11/17/23, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock declined modestly by -0.6%, closing at $55.85. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 6.6% during the last week.

Current PriceTarget Research Rating

With future capital returns forecasted to be above the cost of capital, AMPH is expected to continue to be a major Value Builder.

Amphastar Pharmaceuticals has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Amphastar Pharmaceuticals has a slightly negative Appreciation Score of 34 but a very high Power Rating of 93, leading to the Positive Value Trend Rating.

Be the first to comment

Leave a Reply

Your email address will not be published.